MediWeek

1 in 7 patients with heart failure dies within 90 days of hospitalization in India – Use of standard therapy reduces mortality

One in seven Indian patients with acute decompensated heart failure (ADHF) died within 3 months of hospital admission, reported a study by Harikrishnan et al., published in the journal European Society of Cardiology (ESC) Heart Failure. The study was conducted among 10,851 patients with ADHF (mean age: 59.9 years) from the largest heart failure (HF) […]

1 in 7 patients with heart failure dies within 90 days of hospitalization in India – Use of standard therapy reduces mortality Read More »

DELIVER trial: Cardiovascular benefits of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction

A study published recently in The New England Journal of Medicine(NEJM) reported that treatment with dapagliflozin, a sodium–glucose transporter 2 (SGLT2) inhibitor, reduced the risk of cardiovascular (CV) outcomes in patients with heart failure (HF) and left ventricular ejection fraction (LVEF) >40%. The interventional study, Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved

DELIVER trial: Cardiovascular benefits of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction Read More »

Walk 9,826 steps a day to reduce dementia risk by 50%

A recent study published in JAMA Neurology reported that walking 9,826 steps a day can lower the risk of dementia by half. In addition, steps of higher intensity can further reduce the incident risk. This prospective, observational cohort study, conducted by Del Pozo Cruz B et al. included 78,430 adults (40–79 years of age) from

Walk 9,826 steps a day to reduce dementia risk by 50% Read More »

Shopping Cart
Scroll to Top